| Identification | Back Directory | [Name]
[(1aS,1bα,5aα,6aβ)-1a,1b,2,5a,6,6a-Hexahydro-6α-hydroxy-1aβ-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2α-yl]6-O-α-D-galactopyranosyl-β-D-glucopyranoside | [CAS]
81720-05-0 | [Synonyms]
RhMannioside A
Rehmannioside A
Rehmannia glycosides A
[(1aS,1bα,5aα,6aβ)-1a,1b,2,5a,6,6a-Hexahydro-6α-hydroxy-1aβ-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2α-yl]6-O-α-D-galactopyranosyl-β-D-glucopyranoside
[(1aS,1bα,5aα,6aβ)-1a,1b,2,5a,6,6a-Hexahydro-6α-hydroxy-1aβ-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2α-yl]6-O-α-D-galactopyranosyl-β-D-glucopyranoside
β-D-Glucopyranoside, (1aS,1bS,2S,5aR,6R,6aS)-1a,1b,2,5a,6,6a-hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl 6-O-α-D-galactopyranosyl- | [Molecular Formula]
C21H32O15 | [MDL Number]
MFCD13195577 | [MOL File]
81720-05-0.mol | [Molecular Weight]
524.47 |
| Hazard Information | Back Directory | [Uses]
Rehmannioside A attenuates cognitive deficits in rats with vascular dementia through suppressing oxidative stress, inflammation and apoptosis. |
| Spectrum Detail | Back Directory | [Spectrum Detail]
[(1aS,1bα,5aα,6aβ)-1a,1b,2,5a,6,6a-Hexahydro-6α-hydroxy-1aβ-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2α-yl]6-O-α-D-galactopyranosyl-β-D-glucopyranoside(81720-05-0)1HNMR
|
|
|